Superiority of Dabigatran More Evident in Places Where INR Is Not Well Controlled

At last year's ESC meeting, the RE-LY trial heightened interest in the prospect of dabigatran as a potential replacement for warfarin. Now the RE-LY i...

To continue reading, please log in to the right or request an invitation.